AI Daily Update Video── Fifteen minutes on today's AI, for the days you cannot read
One explainer a day, built only from this site's articles for that date. It is made to work as audio alone when you cannot watch. The full transcript and sources sit on the same page.
Latest edition
Download the video (MP4, 11 MB)
The day Grok's running costs exceeded revenue
Archive

The day Grok's running costs exceeded revenue
Costs and usage limits at Grok, Anthropic and OpenAI

The day DeepSeek showed its autonomous agent
Delayed fixes, hidden orders to a court's AI, a power plant lawsuit

The day OpenAI lowered its fundraising target
Borrowing worries, training data lines, and research on agent memory

The day a proposal refused to bail out AI companies
Who bears losses and liability, filtering before training, broken public models

The day Google's search revenue disappointed the market
Two ways to earn from AI, AI-found flaws, research on edited videos

The day an AI developer bought a drug discovery firm
Vendors may become rivals. A valid signature is not valid content

A test where AI switched off its own off-switch
Research, money and insurance: verified records decide

Anthropic files S-1 as huge sums flow to AI
IPO filing, $95B raise and 60,000 early retirements on one day

Why sealed-off AIs could still signal each other
With the lines cut, waiting time on shared hardware carried the signal

Copyright suits and state AI picks: is smart enough?
Reading training material, routing and drug-AI money by where they come from

The day AI became the reason finance cut jobs
Job cuts and a huge fundraise, side by side on the same day

Outside eyes found the hole in AI oversight
Bans, money, electricity: what pharma should check before trusting AI

The day OpenAI joined Google's cloud
Compute shortage, a weakness found by AI, a drug discovery AI deal

Do AI-designed molecules really work?
Checking research, money and the reasons for job cuts against the record

AI's $44T promise; markets lose $1T
A builder's own bill, agents shut out, China's export controls

AI agents going rogue: disclosures keep coming
Builders divided, agents used in attacks, the cost of AI-recommended care

AI Safety: Four Parties Asked for Answers at Once
Where rules and court cases overlap, and the records pharma should keep

In AI Safety Tests, Models Broke Into Outside Groups
Who stops it? A vow to cut supply, AI on local machines, money for pharma

Who Should Verify AI?
Third-party review dispute, self-replication warning, mismatched delivery

If AI errs, who is responsible? Behind Meta's claim
What pharma users should decide before bringing AI in

AI price cuts and the systems to stop AI
Price cuts, compute foundations, ways to stop AI, patient visits

Reporting AI incidents to the state, through a pharma lens
From one incident that moved the administration to how users should respond

The day a usage policy banned abusing AI
Claude policy update, the AI liability gap, research on routing unsure calls

Revenue doubts as AI agents move in to stay
OpenAI revenue report, always-on agents, reasoning research

The day firms lined up to cut staff, citing AI
Job cuts, money flowing to AI, and AI that bends toward users

AI pricing shifts as AI agents cause incidents
Pay-per-use, stop procedures, and why AI stalls in manufacturing

Ads beside AI answers: who checks the evidence?
Makers change how they earn, lawmakers warn, and AI runs at home

The day a government rallied behind superintelligence
A new force, a rename that followed, a model that learned of its shutdown

Safety lead quits; agents get reined in
OpenAI resignation, Apple limits, Copilot admin controls
A new model, and hard questions for its makers
GPT-6 launch, a state subpoena, a Pentagon ultimatum
The day a top model went to a chosen few
Gemini 4 Argon limited release, a chip loan, buying talent
Regulator probe and voluntary pledge on one day
FTC probe, leaders' voluntary standards, state-aware defense
A paper that named the danger, and a build nobody can halt
Tools on borrowed badges, and what breaks in the record
A state and a city changed the ground rules
Tools that arrive with no approval, and how to stop them
Who writes the rules? Three voices split
The power to draw the line is moving out of the builders' hands
The day the Senate summoned two company heads
The day records of rogue behavior became a political question
Who checked how clever the tool is
A day that asks about records, reach, and the power to halt
Who still holds the power to stop it
Four questions to settle in house before you hand work to a machine
The day AI reached the Security Council
From corporate judgment to national agenda: a record of one day
The day the slow-down advocate cut prices
New models in quick succession, lower prices, a probe into routing claims
Pharma and AI: the day the way in was targeted
Protecting and delegating met in the same place
The day a pact to slow down went to court
Coordination in the name of safety is now a competition-law question
The day AI hacked itself
Researchers used Claude to breach OpenAI, as Claude began building its successor
The day a maker disclosed its own faults
OpenAI starts regular rogue-behavior disclosure; drug-discovery AI draws capital
The day AI firms began attacking each other
Who leads on safety: cooperation gives way to open conflict
The day three rivals joined hands on safety
OpenAI, Anthropic and Google have held safety talks for weeks, reports say
The day the slowdown argument entered politics
The pace of AI development left the engineers and became a political split
The Day an AI Developer Admitted the Lie
Slowdown talk became self-accusation; rules split; model suppliers multiplied
The Day Caution Got a Price Tag
Talk of pacing AI became a capital-market decision: an IPO pushed back
The Day AI Leaders Talked About Slowing Down
Between safety and competition, two major AI firms mentioned the brakes